A retrospective assessment of the safety and efficacy of laparoscopic radical hysterectomy in Japan during the early years following its introduction: a Japanese Gynecologic Oncology Group study (JGOG1081S)

Oncology Group ◽

Laparoscopic Radical Hysterectomy ◽

Oncology Group Study ◽

Safety And Efficacy ◽

Retrospective Assessment

A Randomized Trial of Pelvic Radiation Therapy versus No Further Therapy in Selected Patients with Stage IB Carcinoma of the Cervix after Radical Hysterectomy and Pelvic Lymphadenectomy: A Gynecologic Oncology Group Study

Gynecologic Oncology ◽

10.1006/gyno.1999.5387 ◽

1999 ◽

Vol 73 (2) ◽

pp. 177-183 ◽

Cited By ~ 675

Author(s):

Alexander Sedlis ◽

Brian N. Bundy ◽

Marvin Z. Rotman ◽

Samuel S. Lentz ◽

Laila I. Muderspach ◽

...

Keyword(s):

Radiation Therapy ◽

Randomized Trial ◽

Radical Hysterectomy ◽

Gynecologic Oncology ◽

Pelvic Lymphadenectomy ◽

Oncology Group ◽

Oncology Group Study ◽

Pelvic Radiation ◽

Stage Ib

Intermediate-risk grouping of cervical cancer patients treated with radical hysterectomy: a Korean Gynecologic Oncology Group study

British Journal of Cancer ◽

10.1038/bjc.2013.716 ◽

2013 ◽

Vol 110 (2) ◽

pp. 278-285 ◽

Cited By ~ 31

Author(s):

S Y Ryu ◽

M H Kim ◽

B H Nam ◽

T S Lee ◽

E S Song ◽

...

Keyword(s):

Cervical Cancer ◽

Cancer Patients ◽

Radical Hysterectomy ◽

Gynecologic Oncology ◽

Intermediate Risk ◽

Oncology Group ◽

Oncology Group Study ◽

Risk Grouping

Comparison of laparoscopic and abdominal radical hysterectomy in early stage cervical cancer patients without adjuvant treatment: Ancillary analysis of a Korean Gynecologic Oncology Group Study (KGOG 1028)

Gynecologic Oncology ◽

10.1016/j.ygyno.2019.06.023 ◽

2019 ◽

Vol 154 (3) ◽

pp. 547-553 ◽

Cited By ~ 23

Author(s):

E Sun Paik ◽

Myong Cheol Lim ◽

Moon-Hong Kim ◽

Yun Hwan Kim ◽

Eun Seop Song ◽

...

Keyword(s):

Cervical Cancer ◽

Cancer Patients ◽

Adjuvant Treatment ◽

Radical Hysterectomy ◽

Early Stage ◽

Gynecologic Oncology ◽

Oncology Group ◽

Oncology Group Study ◽

Early Stage Cervical Cancer

Phase II study of neoadjuvant chemotherapy with irinotecan hydrochloride and nedaplatin followed by radical hysterectomy for bulky stage Ib2 to IIb, cervical squamous cell carcinoma: Japanese Gynecologic Oncology Group study (JGOG 1065)

Oncology Reports ◽

10.3892/or.2012.1814 ◽

2012 ◽

Vol 28 (2) ◽

pp. 487-493 ◽

Cited By ~ 23

Author(s):

SATOSHI YAMAGUCHI ◽

RYUICHIRO NISHIMURA ◽

NOBUO YAEGASHI ◽

KAZUSHIGE KIGUCHI ◽

TORU SUGIYAMA ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Neoadjuvant Chemotherapy ◽

Radical Hysterectomy ◽

Phase Ii Study ◽

Gynecologic Oncology ◽

Cervical Squamous Cell Carcinoma ◽

Oncology Group ◽

Oncology Group Study ◽

Irinotecan Hydrochloride

Chemoradiation With Paclitaxel and Carboplatin in High-Risk Cervical Cancer Patients After Radical Hysterectomy: A Korean Gynecologic Oncology Group Study

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2013.01.035 ◽

2013 ◽

Vol 86 (2) ◽

pp. 304-310 ◽

Cited By ~ 8

Author(s):

Taek Sang Lee ◽

Soon Beom Kang ◽

Young Tak Kim ◽

Byung Joo Park ◽

Yong Man Kim ◽

...

Keyword(s):

Cervical Cancer ◽

High Risk ◽

Cancer Patients ◽

Radical Hysterectomy ◽

Gynecologic Oncology ◽

Oncology Group ◽

The Abandoned Radical Hysterectomy: A Gynecologic Oncology Group Study

Gynecologic Oncology ◽

10.1006/gyno.2000.5993 ◽

2000 ◽

Vol 79 (3) ◽

pp. 350-356 ◽

Cited By ~ 34

Author(s):

Charles W. Whitney ◽

Frederick B. Stehman

Keyword(s):

Radical Hysterectomy ◽

Gynecologic Oncology ◽

Oncology Group ◽

Phase II trial of weekly paclitaxel (80 mg/m2) in platinum and paclitaxel-resistant ovarian and primary peritoneal cancers: A Gynecologic Oncology Group study

Yearbook of Oncology ◽

10.1016/s1040-1741(08)70331-2 ◽

2007 ◽

Vol 2007 ◽

pp. 82-83

Author(s):

J.T. Thigpen

Keyword(s):

Phase Ii ◽

Phase Ii Trial ◽

Gynecologic Oncology ◽

Weekly Paclitaxel ◽

Oncology Group ◽

Whole Abdominal Radiotherapy in the Adjuvant Treatment of Patients With Stage III and IV Endometrial Cancer: A Gynecologic Oncology Group Study

Yearbook of Obstetrics Gynecology and Women s Health ◽

10.1016/s1090-798x(08)70597-6 ◽

2006 ◽

Vol 2006 ◽

pp. 449-452

Author(s):

S.D. Yamada

Keyword(s):

Endometrial Cancer ◽

Adjuvant Treatment ◽

Gynecologic Oncology ◽

Stage Iii ◽

Oncology Group ◽

Oncology Group Study ◽

Abdominal Radiotherapy

Faculty Opinions recommendation of Phase II trial of combination bevacizumab and temsirolimus in the treatment of recurrent or persistent endometrial carcinoma: a Gynecologic Oncology Group study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717969752.793471344 ◽

2013 ◽

Author(s):

David Kushner ◽

Ryan Spencer

Keyword(s):

Endometrial Carcinoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Gynecologic Oncology ◽

Oncology Group ◽

Faculty Opinions recommendation of A phase II evaluation of nintedanib (BIBF-1120) in the treatment of recurrent or persistent endometrial cancer: an NRG Oncology/Gynecologic Oncology Group Study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.722006345.793527263 ◽

2017 ◽

Author(s):

Paola Gehrig

Keyword(s):

Endometrial Cancer ◽

Phase Ii ◽

Gynecologic Oncology ◽

Oncology Group ◽

Oncology Group Study ◽

Bibf 1120